Cellectis - ADRCLLS
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 27 institutions reported holding Cellectis - ADR (CLLS) in their 13F filings, unchanged from Q2 2024. 2 opened new positions and 2 sold out. The largest holders were Long Focus Capital Management, LLC ($9.9M), Capital International Investors ($4.0M) and UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ($3.0M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cellectis - ADR
- CUSIP
- 15117K103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $73K |
| Exits | 2 | $268 |
All 13F filers, Q2 2024 → Q3 2024: 42,589 shares bought and 48,836 shares sold, net −6,247 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Long Focus Capital Management, LLC | 0.87% | No change | 4,617,293 | $9.9M |
| Capital International Investors | 0.00% | No change | 1,848,804 | $4.0M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | No change | 1,438,255 | $3.0M |
| Baillie Gifford & Co. | 0.00% | Reduce -1.9% | 693,939 | $1.5M |
| Principal Financial Group Inc. | 0.00% | Reduce -5.8% | 411,800 | $881K |
| Macquarie Group Ltd. | 0.00% | No change | 226,875 | $486K |
| KBC Group NV | 0.00% | No change | 163,447 | $347K |
| LPL Financial LLC | 0.00% | Add +0.6% | 92,372 | $196K |
| Morgan Stanley | 0.00% | Add +6.0% | 91,525 | $194K |
| Two Sigma Investments, LP | 0.00% | Reduce -17.1% | 33,412 | $71K |
| Citadel Advisors | 0.00% | Add +3.5% | 27,624 | $59K |
| First Affirmative Financial Network | 0.02% | New | 21,094 | $45K |
| BNP Paribas Financial Markets | 0.00% | Add +10.2% | 18,400 | $39K |
| Baird Financial Group, Inc. | 0.00% | No change | 15,090 | $32K |
| XTX Topco Ltd | 0.00% | Reduce -14.5% | 13,095 | $28K |
| Susquehanna International Group, LLP | 0.00% | New | 13,010 | $28K |
| Wells Fargo & Company | 0.00% | Reduce -5.5% | 12,090 | $26K |
| Geode Capital Management, LLC | 0.00% | No change | 10,776 | $23K |
| Harbour Investments, Inc. | 0.00% | No change | 6,100 | $13K |
| Rhumbline Advisers | 0.00% | No change | 3,855 | $8K |
| National Bank of Canada | 0.00% | No change | 3,600 | $8K |
| BlackRock, Inc. | 0.00% | — | 2,755 | $6K |
| Allworth Financial LP | 0.00% | No change | 500 | $1K |
| POM Investment Strategies, LLC | 0.00% | No change | 495 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 83 | $178 |
| Bank of America Corp. | 0.00% | Add +3750.0% | 77 | $163 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 13 | $28 |
"% of holder's portfolio" is CLLS's weight in each manager's 13F, not the share of Cellectis - ADR the manager owns.